ES403542A1 - Substituted phenylimidazolidinones the acid addition salts thereof and processes for their preparation - Google Patents
Substituted phenylimidazolidinones the acid addition salts thereof and processes for their preparationInfo
- Publication number
- ES403542A1 ES403542A1 ES403542A ES403542A ES403542A1 ES 403542 A1 ES403542 A1 ES 403542A1 ES 403542 A ES403542 A ES 403542A ES 403542 A ES403542 A ES 403542A ES 403542 A1 ES403542 A1 ES 403542A1
- Authority
- ES
- Spain
- Prior art keywords
- formula
- group
- preparation
- compound
- chr2
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/30—Oxygen or sulfur atoms
- C07D233/32—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Procedure for the preparation of compounds of the formula **(See formula)** wherein R is hydrogen, an alcohol or lower alkoxy group, or a halogen atom; R'means one of the groups, in the target positions or for -CHR1-Q-A, -CHR2-A and -O-CHR2-CHR1-Q-A, where A represents radicals **(See formula)** Q means a branched or unbranched alcoholic chain with 1 to 4 carbon atoms, R1 means the hydrogen atom, the hydroxy group, a lower alkoxy group or the group -Q-CO-R5, R2 means the hydrogen atom or the methyl group, R3 and R4, which may be the same or different, represent the hydrogen atom, an alcohol or lower alkoxy group, a halogen atom or the trifluoromethyl group, or together also a 5- or 6-membered ring, aliphatic or aromatic, adjacent condensed, R5 signifies a lower alcohol group, which may be substituted by halogen, hydroxy or alkoxy, the amino group or a monoalkoxylamino or dialcoylamino group, Z means an aromatic ring with 1 to 2 heteroatoms, with which it can also be adjacently fused a benzene ring, and in which R'' designates the hydrogen atom or an alcoholic, alkenyl, alkynyl, hydroxyalkoxy, dialkoylaminoalkoxy or lower aralkoxy radical, branched or unbranched, as well as the corresponding acid addition salts, characterized in that a) an amine of the formula is reacted H-A (II) with a compound of the formula **(See formula)** where Ra represents one of the groups, in the meta positions or for -CHR2-X, -CHR1-Q-X and -O-CHR2-CHR1-Q-X in which X means a radical capable of being separated with the hydrogen from the compound HA in the form of HX, in the presence of an HX fixing agent; or because b) for the preparation of the compounds according to the invention in which R1 signifies the hydrogen atom, the hydroxy group or a lower alkoxy group, a ring closure is carried out in a corresponding compound of the formula **(See formula)** or because c) for the preparation of the compounds of formula I, in which R'' does not represent a hydroxyalkyl radical, R1 does not represent the hydroxy group and R5 does not represent a hydroxyalkyl radical, the amino group or a monoalkoxy amino group, a ring closure is performed on ethylene diamine derivatives of the formula **(See formula)** with appropriate carbonic acid derivatives or with metal cyanates in the presence of acids; or because d) for the preparation of the compounds according to the invention in which A designates the radical **(See formula)** a compound of the formula is subjected to reductive amination **(See formula)** where Rb means one of the groups, in the target positions or for -CHO, -CHR1-CnH2n-1O and -O-CHR2-CHR1-CnH2n-1O (n equal to 1, 2, 3 or 4), with an amine of the formula HA; or because e) for the preparation of the compounds of the formula I, in which R'means the radical -CHOH-Q-A, ketones of the formula are reduced **(See formula)** or because f) for the preparation of the compounds of the formula I, in which it means hydrogen and R'' means a radical R''1, the OH group is removed from a compound of the formula **(See formula)** in which R''1 signifies an alcoholic, alkoxyalkoyl or lower aralkoyl radical and R0 represents one of the radicals, in the meta or para positions of the formula -CR2OH-A, -CHOH-Q-A or -O-CHR2-CHOH-Q-A or because, g) for the preparation of the compounds of the general formula I, in which R1 signifies the hydroxy group, a compound of the formula is reacted **(See formula)** where Rd means one of the radicals, in the meta or para positions, of the formulas **(See formula)** wherein R6 and R7 signify hydrogen or alcohol radicals having together up to 3 carbon atoms, with an amine of the formula H-A; or because h) for the preparation of the compounds of the formula I, in which R1 represents the hydrogen atom, a lower alkoxy group or the group -O-CO-R5, in which R5 is an alcoholic or alkoxyalcoyl group or a dialkoxylamino group, a compound of the formula is reacted **(See formula)** where R'has the preceding meanings, limited as regards R1, and Me + signifies an alkali metal cation, with a corresponding compound R''X; or why i) for the preparation of compounds of formula I, in which R'represents the radical -O-CHR2-CH2-Q-A a phenol of the formula is reacted **(See formula)** wherein the phenolic OH group is in the meta or para positions, with a compound of the formula X-CHR2-CH2-Q-A in the presence of an acid binding agent; or because k) for the preparation of compounds of the formula I, in which R1 signifies an alkoxy group or a group -O-CO-R5 and R'' does not signify the hydroxyalkyl group, a compound of the formula is reacted **(See formula)** where Re represents one of the radicals in meta positions or for -CHOH-Q-A or -O-CHR2-CHOH-Q-A with an agent to replace the hydrogen of the OH by means of an alcoholic group or with a group -CO-R5; and because eventually the bases, obtained primarily according to the process modes a) to k), are transformed into acid addition salts, the acid addition salts, obtained primarily in said procedures, are transformed into free bases, and/or eventually a doubling is carried out into diastereoisomers or optical antipodes. (Machine-translation by Google Translate, not legally binding)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT492071A AT311956B (en) | 1971-06-07 | 1971-06-07 | Process for the preparation of new phenylimidazolidinone derivatives and their salts |
Publications (1)
Publication Number | Publication Date |
---|---|
ES403542A1 true ES403542A1 (en) | 1975-05-01 |
Family
ID=3569889
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES403542A Expired ES403542A1 (en) | 1971-06-07 | 1972-06-06 | Substituted phenylimidazolidinones the acid addition salts thereof and processes for their preparation |
Country Status (20)
Country | Link |
---|---|
AR (7) | AR200112A1 (en) |
AT (1) | AT311956B (en) |
AU (1) | AU473287B2 (en) |
BE (1) | BE784475A (en) |
BG (1) | BG22822A3 (en) |
CA (1) | CA1011336A (en) |
CH (7) | CH591475A5 (en) |
DD (1) | DD101403A5 (en) |
DE (1) | DE2223751A1 (en) |
ES (1) | ES403542A1 (en) |
FR (1) | FR2140492B1 (en) |
GB (1) | GB1391491A (en) |
HU (1) | HU165493B (en) |
IE (1) | IE37812B1 (en) |
IL (1) | IL39620A (en) |
NL (1) | NL7207701A (en) |
NO (1) | NO136841C (en) |
SE (1) | SE392902B (en) |
SU (8) | SU453839A3 (en) |
ZA (1) | ZA723840B (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19822678A1 (en) * | 1998-05-20 | 1999-11-25 | Bayer Ag | New 1,3-diaza-2-oxo-cycloalkane derivatives, useful as pre- or post-emergence, total or selective herbicides |
WO2004106292A1 (en) * | 2003-05-28 | 2004-12-09 | Imotep Inc. | Haloethyl urea compounds and their use to attenuate, inhibit or prevent non-cancerous pathogenic cellular proliferation and diseases associated therewith |
WO2004106291A1 (en) * | 2003-05-28 | 2004-12-09 | Imotep Inc. | Haloethyl urea compounds and the use thereof to attenuate, inhibit or prevent cancer cell migration |
RU2497810C1 (en) * | 2012-06-28 | 2013-11-10 | Общество с ограниченной ответственностью "Объединенный центр исследований и разработок" | Method of obtaining n,n-diaryl-substituted 2-trichloromethyl-imidazolidines |
-
1971
- 1971-06-07 AT AT492071A patent/AT311956B/en not_active IP Right Cessation
-
1972
- 1972-05-16 DE DE19722223751 patent/DE2223751A1/en active Pending
- 1972-05-31 SU SU1791532A patent/SU453839A3/en active
- 1972-05-31 SU SU1970169A patent/SU493067A3/en active
- 1972-06-05 CA CA143,854A patent/CA1011336A/en not_active Expired
- 1972-06-05 BG BG020655A patent/BG22822A3/en unknown
- 1972-06-06 SE SE7207420A patent/SE392902B/en unknown
- 1972-06-06 CH CH1507275A patent/CH591475A5/xx not_active IP Right Cessation
- 1972-06-06 CH CH1507675A patent/CH589646A5/xx not_active IP Right Cessation
- 1972-06-06 HU HUBO1379A patent/HU165493B/hu unknown
- 1972-06-06 CH CH1507475A patent/CH589644A5/xx not_active IP Right Cessation
- 1972-06-06 DD DD163478A patent/DD101403A5/en unknown
- 1972-06-06 CH CH1507375A patent/CH590269A5/xx not_active IP Right Cessation
- 1972-06-06 BE BE784475A patent/BE784475A/en unknown
- 1972-06-06 CH CH1507175A patent/CH583729A5/xx not_active IP Right Cessation
- 1972-06-06 AU AU43129/72A patent/AU473287B2/en not_active Expired
- 1972-06-06 ES ES403542A patent/ES403542A1/en not_active Expired
- 1972-06-06 ZA ZA723840A patent/ZA723840B/en unknown
- 1972-06-06 CH CH1507575A patent/CH589645A5/xx not_active IP Right Cessation
- 1972-06-06 CH CH840072A patent/CH573425A5/xx not_active IP Right Cessation
- 1972-06-06 NO NO2007/72A patent/NO136841C/en unknown
- 1972-06-06 IL IL39620A patent/IL39620A/en unknown
- 1972-06-06 FR FR7220319A patent/FR2140492B1/fr not_active Expired
- 1972-06-07 IE IE791/72A patent/IE37812B1/en unknown
- 1972-06-07 GB GB2662372A patent/GB1391491A/en not_active Expired
- 1972-06-07 AR AR242433A patent/AR200112A1/en active
- 1972-06-07 NL NL7207701A patent/NL7207701A/xx unknown
-
1973
- 1973-01-01 AR AR249758A patent/AR205522A1/en active
- 1973-01-01 AR AR249754A patent/AR207109A1/en active
- 1973-08-24 AR AR249755A patent/AR202904A1/en active
- 1973-08-24 AR AR249752A patent/AR202903A1/en active
- 1973-08-24 AR AR249757A patent/AR200139A1/en active
- 1973-08-24 AR AR249753A patent/AR203017A1/en active
- 1973-11-14 SU SU1970168A patent/SU503516A3/en active
- 1973-11-14 SU SU1970171A patent/SU492085A3/en active
- 1973-11-14 SU SU1970242A patent/SU509228A3/en active
- 1973-11-14 SU SU1970164A patent/SU499806A3/en active
- 1973-11-14 SU SU1970167A patent/SU505358A3/en active
- 1973-11-14 SU SU1970170A patent/SU498907A3/en active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES403542A1 (en) | Substituted phenylimidazolidinones the acid addition salts thereof and processes for their preparation | |
ES2037779T3 (en) | PROCEDURE FOR PREPARING NEW AMIDA COMPOUNDS. | |
ES450995A1 (en) | 4-amino-quinoline derivatives process for their preparation and therapeutic applications thereof | |
ES493599A0 (en) | A PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF AZETI DIN-2-ONA. | |
US2376112A (en) | Amination of dihydric phenols | |
ES418827A1 (en) | 2-aminoindane derivatives | |
GB2021559A (en) | Benzylidene derivatives | |
ES378202A1 (en) | 2-(imidazolid inylidence-(2)-amino)-5-nitro-thiazoles and salts thereof | |
DE69015208D1 (en) | DERIVATIVES OF GLUTAMINE AND ASPARGINIC ACID WITH ANTIGASTRINE EFFECT AND METHOD FOR THE PRODUCTION THEREOF. | |
EP0145236A3 (en) | Thiadiazinone compounds, process for their preparation, and pharmaceutical compositions containing them | |
PT71598A (en) | Process for preparing n-aminoalkyl -indol derivatives | |
GB1382602A (en) | Benzodioxan compounds and process for preparing the same | |
ES531941A0 (en) | PROCEDURE FOR PREPARING AFIDICOLINE DERIVATIVES. | |
GB1451180A (en) | Alkylsulphonylphenoxypropanolamines | |
Meltsner et al. | Alkanolamines. V. Reaction of m-dinitrobenzene with ethanolamines | |
ES316907A1 (en) | A procedure for the manufacture of amino pharmaceutical compounds. (Machine-translation by Google Translate, not legally binding) | |
ES528460A0 (en) | PROCEDURE FOR THE PREPARATION OF NEW ALFA-ETIBENZOL DERIVATIVES WITH A SUBSTITUTED AMINO PROPANOLIC GROUP AND ITS ADDITIONAL SALTS ACID AND QUATERNARY AMMONICS. | |
ES303423A1 (en) | Procedure for the obtaining of new 1-aryloxi-2-hydroxy-3-isopropilamine-propanes and of their salts. (Machine-translation by Google Translate, not legally binding) | |
ES419548A1 (en) | N-(indazolyl-n1-methyl)dialkanolamines | |
ES411018A2 (en) | Derivatives of 4,-aminomethyl-dibenzo-b,e- 11-oxepine-2,- spiro- 1,3, -dioxolane their method of preparation and their thera peutic application | |
ES393340A1 (en) | Amines and a process for the manufacture thereof | |
MX3332E (en) | PROCEDURE FOR THE PREPARATION OF DIPEPTIDE DERIVATIVES | |
GB835893A (en) | New acylamino-compounds and process for their manufacture | |
ES281441A1 (en) | A procedure for the manufacture of pharmaceutical compounds (Machine-translation by Google Translate, not legally binding) | |
ES484287A1 (en) | Procedure for the obtaining of N- (1- (4-amino-2-quinazolinil) -3-0-4-piperidil-lactamas. (Machine-translation by Google Translate, not legally binding) |